Search research articles
Contact Us
Filters
Showing results (1-10 of 106) with videos related to
Page
of 11
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
October 9, 2002
Tamoxifen maculopathy
Amar Alwitry, Iain Gardner
Molecular Immunology
|
August 7, 2013
Are endosomal trafficking parameters better targets for improving mAb pharmacokinetics than FcRn binding affinity?
Brian Gurbaxani, Miroslav Dostalek, Iain Gardner
Antibiotics (Basel, Switzerland)
|
September 28, 2024
Application of Physiologically Based Pharmacokinetic Model to Delineate the Impact of Aging and Renal Impairment on Ceftazidime Clearance
Khaled Abduljalil, Iain Gardner, Masoud Jamei
Pharmaceutics
|
April 27, 2024
An Application of a Physiologically Based Pharmacokinetic Approach to Predict Ceftazidime Pharmacokinetics in a Pregnant Population
Khaled Abduljalil, Iain Gardner, Masoud Jamei
Frontiers in Pediatrics
|
June 2, 2022
Application of a Physiologically Based Pharmacokinetic Approach to Predict Theophylline Pharmacokinetics Using Virtual Non-Pregnant, Pregnant, Fetal, Breast-Feeding, and Neonatal Populations
Khaled Abduljalil, Iain Gardner, Masoud Jamei
Pharmaceuticals (Basel, Switzerland)
|
February 27, 2026
Physiologically Based Pharmacokinetic Modelling of Hydroxyurea in Patients with Sickle Cell Disease: A Special Focus on Lactating Women and Breastfed Infants to Inform Safe Dosing and Breastfeeding Strategies
Khaled Abduljalil, Neel Deferm, Anna Murphy, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
July 15, 2022
Physiologically-Based Pharmacokinetic Models of CYP2D6 Substrate and Inhibitors Nebivolol, Cinacalcet and Mirabegron to Simulate Drug-Drug Interactions
Peter Kilford, Nika Khoshaein, Roz Southall, et al.
Current Drug Metabolism
|
December 20, 2003
Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist
Kevin Beaumont, Robert Webster, Iain Gardner, et al.
Briefings in Bioinformatics
|
February 10, 2025
The role of automation in enhancing reproducibility and interoperability of PBPK models
Abdallah Derbalah, Masoud Jamei, Iain Gardner, et al.
The AAPS Journal
|
July 10, 2014
Simulation of monoclonal antibody pharmacokinetics in humans using a minimal physiologically based model
Linzhong Li, Iain Gardner, Miroslav Dostalek, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 106) with videos related to
Sort By:
Page
of 11
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
October 9, 2002
Tamoxifen maculopathy
Amar Alwitry, Iain Gardner
Molecular Immunology
|
August 7, 2013
Are endosomal trafficking parameters better targets for improving mAb pharmacokinetics than FcRn binding affinity?
Brian Gurbaxani, Miroslav Dostalek, Iain Gardner
Antibiotics (Basel, Switzerland)
|
September 28, 2024
Application of Physiologically Based Pharmacokinetic Model to Delineate the Impact of Aging and Renal Impairment on Ceftazidime Clearance
Khaled Abduljalil, Iain Gardner, Masoud Jamei
Pharmaceutics
|
April 27, 2024
An Application of a Physiologically Based Pharmacokinetic Approach to Predict Ceftazidime Pharmacokinetics in a Pregnant Population
Khaled Abduljalil, Iain Gardner, Masoud Jamei
Frontiers in Pediatrics
|
June 2, 2022
Application of a Physiologically Based Pharmacokinetic Approach to Predict Theophylline Pharmacokinetics Using Virtual Non-Pregnant, Pregnant, Fetal, Breast-Feeding, and Neonatal Populations
Khaled Abduljalil, Iain Gardner, Masoud Jamei
Pharmaceuticals (Basel, Switzerland)
|
February 27, 2026
Physiologically Based Pharmacokinetic Modelling of Hydroxyurea in Patients with Sickle Cell Disease: A Special Focus on Lactating Women and Breastfed Infants to Inform Safe Dosing and Breastfeeding Strategies
Khaled Abduljalil, Neel Deferm, Anna Murphy, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
July 15, 2022
Physiologically-Based Pharmacokinetic Models of CYP2D6 Substrate and Inhibitors Nebivolol, Cinacalcet and Mirabegron to Simulate Drug-Drug Interactions
Peter Kilford, Nika Khoshaein, Roz Southall, et al.
Current Drug Metabolism
|
December 20, 2003
Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist
Kevin Beaumont, Robert Webster, Iain Gardner, et al.
Briefings in Bioinformatics
|
February 10, 2025
The role of automation in enhancing reproducibility and interoperability of PBPK models
Abdallah Derbalah, Masoud Jamei, Iain Gardner, et al.
The AAPS Journal
|
July 10, 2014
Simulation of monoclonal antibody pharmacokinetics in humans using a minimal physiologically based model
Linzhong Li, Iain Gardner, Miroslav Dostalek, et al.
Page
of 11